Apresentação Pessoal

Graduated in Veterinary Medicine by the Abel Salazar Institute of Biomedical Sciences (ICBAS), University of Porto (2007). PhD in Veterinary Sciences by ICBAS in the area of ​​oncology (2012). Assistant professor at the Faculty of Veterinary Medicine of the Lusophone University of Humanities and Technologies (FMV-ULHT), in Lisbon (2013-2017). Responsible for the oncology service of the school hospital at FMV-ULHT (2013-2017). Assistant professor at the School of Science and Technology at the University of Évora (2018). Assistant professor in the Department of Veterinary Clinics at ICBAS (2019 to date). Affiliation as a researcher at CECA-ICETA (since 2015). Training in internal medicine and veterinary oncology at the University of Tennessee-USA (2005-2006), at the University of Wisconsin-Madison - USA (2011) and at the Royal Veterinary College-UK (2014). Author of several publications in international veterinary scientific journals and guest speaker at several congresses and courses in the field of oncology.

Publications in scientific journals:

1- Santos, A., Lopes, C., Marques, R. M., Amorim, I., Ribeiro, J., Frias, C., Vicente, C., Gärtner, Matos, A. (2011). Immunohistochemical analysis of urokinase plasminogen activator and its prognostic value in canine mammary tumours. The Veterinary Journal 189: 43-48. doi: 10.1016/j.tvjl.2010.05.02

2- Santos A., Oliveira JT, Lopes CC, Amorim, IF, Vicente, CM, Gärtner FR, Matos, AJ (2010). Immunohistochemical expression of VEGF in Canine Mammary Tumours. Journal Comparative Pathology 143(4): 268-75. doi: 10.1016/j.jcpa.2010.04.006

 3- Santos, A., Lopes, C., Frias, C., Amorim, I., Vicente. C., Gärtner, F., Matos, A. (2011) Immunohistochemical evaluation of MMP-2 and TIMP-2 in canine mammary tumours: A survival study. The Veterinary Journal 190, 396-402.doi: 10.1016/j.tvjl.2010.12.003

4- Santos, A. A.; Lopes, C. C.; Marques, R. R.; Amorim, I. F.; Gärtner, M. F., Matos, A.J.F. (2012). Matrix Metalloproteinase-9 expression in mammary gland tumors in dogs and its relationship with prognostic factos and patient outcome. American Journal of Veterinary Research 73, 689-697. doi: 10.2460/ajvr.73.5.689

5- Santos, A., Lopes, C. C., Ribeiro, J. R., Martins, L. R., Santos, J. C., Amorim, I. F., Gärtner, F., Matos, A. J. (2013). Identification of prognostic factors in canine mammary malignant tumours: a multivariable survival study. BMC Veterinary Research 9:1. doi: 10.1186/1746-6148-9-1.

6- Santos, A., Lopes, C., Gärtner, F., Matos, A.J.F, 2014. VEGFR-2 expression in malignant tumours of the canine mammary gland: A prospective survival study. Veterinary Comparative Oncology. doi: 10.1111/vco.12107

7 - Santos, M., Correia-Gomes, C., Santos, A., Matos, A., Rocha, E., Lopes, C., Dias Pereira, P. (2014). Nuclear Polimorphism: Role in grading and prognosis of canine mammary carcinomas. The Veterinary Journal 200, 426-433. doi: 10.1016/j.tvjl.2014.03.019

8 - Santos, M., Correia-Gomes, C., Marcos, R., Santos, A., Matos, A., Lopes, C., Dias Pereira, P. (2015). Value of Nottingham Histological Grading Parameters and Nottingham Prognostic Index in Canine Mammary Carcinoma. Anticancer Research 35, 4219-4228. PMID: 26124382

9 - Santos, M., Correia-Gomes, C., Santos, A., Matos, A., Dias Pereira, P.,  Lopes, C. (2015). Interobserver Reproducibility of Histological Grading of Canine Simple Mammary Carcinomas. Journal Comparative Pathology 153, 22-27. doi: 10.1016/j.jcpa.2015.04.005

10 - Matos, A.J.F., Santos, A. (2015). Advances in the understanding of the clinically relevant genetic pathways and molecular aspects of canine mammary tumours: Part 1. Proliferation, apoptosis and DNA repair. The Veterinary Journal 205, 136-143. doi: 10.1016/j.tvjl.2015.02.004

11 - Santos, A., Matos, A.J.F. (2015). Advances in the understanding of the clinically relevant genetic pathways and molecular aspects of canine mammary tumours. Part 2: Invasion, angiogenesis, metastasis and therapy. The Veterinary Journal 205, 144-153. doi: 10.1016/j.tvjl.2015.03.029

12 - Ramos, S.C., Matos, A.J.F., Ribeiro, J.N, Leite-Martins, L.R., Ferreira, R.R.F., Viegas, I., Santos, A. (2017). Serum levels of urokinase-type plasminogen activator n healthy dogs and in oncologic canine patients. Veterinary World 10 (8), 918-923.

13 – Viegas, C., Matos, A.J.F., Leite-Martins, L.R., Viegas, I., Ferreira, R.R.F., Gregório, H., Santos, A. (2020). Determination of urokinase-type plasminogen activator serum levels in healthy and oncologic cats. Canadian Journal of veterinary Research 84 (1): 60-66. 

14- Pinello, K.C, Queiroga, F., de Matos, A., Santos, A., Ribeiro, J.N., Guscetti, F., Palmieri, C., Momanyi, K., Torres, JR, Killick, D., Radford, A., Wilson-Robles, H., Carvalho, JP, Tedardi, MV, Dagli, ML (2020). The Global Initiative for Veterinary Cancer Surveillance (GIVCS): Report of the first meeting and future perspectives. Veterinary Comparative Oncology 1-2. DOI: 10.1111/vco.12577

15 – Simões, PB, Costa, A, Santos, A, Marcos, R (2020). Blood from a “half-fish” dog: How modern analyzers deal with nucleated red blood cells. Veterinary Clinical Pathology 49:8-10. doi.org/10.1111/vcp.12844.

Abstracts presented in international congresses:

1 - Santos, A., Oliveira, J., Lopes, C., Vicente, C., Amorim, I., Gärtner, F., Matos, A., 2009. Immunohistochemical of VEGF in Canine Mammary Tumours. Abstracts from European Society of Veterinary Oncology Annual Congress, pp 7. Visegrád, Hungary, March 2009. 

2- Santos, A., Lopes, C., Amorim, I., Gärtner, F., Matos, A.J.F., 2009. Immunohistochemical expression of VEGF in canine mammary gland tumours and in regional and distant metastasis. Abstracts from 19th Congress of The European College of veterinary Internal Medicine - Companion Animals, pp 232. Porto, Portugal, September 2009.

3 - Santos, A., Lopes, C., Amorim, I., Frias, C., Vicente, C., Gärtner, F., Matos, A., 2010. Urokinase Plasminogen Activator protein expression and its prognostic value in canine mammary tumours. Abstracts from European Society of Veterinary Oncology Spring Congress, pp 26. Turin, Italy, March 2010.

4 - Santos, A., Lopes, C.C., Marques, R.M., Amorim, I., Frias, C., Gärtner, F., Matos, A.J.F., 2011. MMP-9 immunoexpression in canine mammary gland tumours: relationship with poor prognostic factors and patient’s outcome. Abstracts from European Society of Veterinary Oncology Annual Congress, pp 14. Glasgow, Sctoland, March 2011.

5 - Santos, A., Lopes, C., Frias, C., Gärtner, F., Matos, A., 2012. The prognostic value of VEGFR2 in female dogs with mammary gland tumours: a univariate survival study. Abstracts from 2nd World Veterinary Cancer Congress, pp 10. Paris, France, March 2012.

6- Ramos, S.C.M., Matos, A.J.F, Ribeiro, J.N., Martins, L.R.L, Ferreira, R.R.F, Santos, A.A. Serum levels of urokinase-type plasminogen activatorn canine patients with cancer. Abstracts from 3rd World Veterinary Cancer Congress, pp 65. Foz do Iguassu, Brasil, 2016.

7- Viegas, AC; Matos, AF; Ferreira, R; Villa Nova, M; Gregório, H; Martins, L., Santos, A. Determination and comparison of urokinase plasminogen activator serum levels among healthy cats and cats with oncologic disease. ESVONC congress 2017, pp 31 Lyon, France.

8- Batista, C., Santos, A., Villagrasa, M., Matos, A.J.F. Diagnostic imaging findings of uncommon sites for distant metastasis in canine mammary tumours. Abstracts from Annual Congress of the European Veterinary Diagnostic Imaging (EVDI), Vol. 55 Nº. 6 p. 668, Portugal, 2013.

9- Pinello, KC; Martins, L; Gregório, H; Santos, A; Queiroga, FL; Oliveira, F; Tedardi, MV; Dagli, ML; Niza-Ribeiro, J; de Matos, AJ. Implementation and preliminary results of an Animal Cancer Registry in Portugal (RCA-PT) in partnership with RCA-SP. ESVONC congress 2017, Lyon, France.

10 – Romão, R., Almeida, A.L., Santos, A., Lança, M.J. (2019). The evolution of practical veterinary anatomy teaching in the University of Évora – the use of cadavers: privilege or triviality? Poster in the I International Congress of Education in Animal Sciences (ICEAS), Évora, Portugal.

 

Áreas de Interesse

1. Health sciences